000 | 01188 a2200337 4500 | ||
---|---|---|---|
005 | 20250512224914.0 | ||
264 | 0 | _c19840320 | |
008 | 198403s 0 0 eng d | ||
022 | _a0195-668X | ||
024 | 7 |
_a10.1093/eurheartj/4.suppl_h.43 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFleckenstein, A | |
245 | 0 | 0 |
_aConsequences of uncontrolled calcium entry and its prevention with calcium antagonists. _h[electronic resource] |
260 |
_bEuropean heart journal _cDec 1983 |
||
300 |
_a43-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
650 | 0 | 4 |
_aCardiomyopathies _xpathology |
650 | 0 | 4 |
_aIsoproterenol _xpharmacology |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 |
_aNecrosis _xprevention & control |
650 | 0 | 4 | _aRats |
700 | 1 | _aFrey, M | |
700 | 1 | _aFleckenstein-GrĂ¼n, G | |
773 | 0 |
_tEuropean heart journal _gvol. 4 Suppl H _gp. 43-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/eurheartj/4.suppl_h.43 _zAvailable from publisher's website |
999 |
_c6661938 _d6661938 |